Market Highlights
Textile implants are used in Hernia repair products nerve conduits, cardiovascular plugs, heart valve sewing cuffs, collapsible orthopedic anchors, diabetic wound care tissue scaffolds, osteoconductive bone grafts, scoliosis correction devices, suture loops, sternal closure devices, partially to fully resorbable soft tissue repair products, drug and device combination products. The market is driven by the increasing prevalence of sports injuries and orthopedic surgeries, rising prevalence of cardiovascular diseases, increasing prevalence of breast and prostate cancer and technological advancements in textile implants, rising geriatric population, increasing research on textile implants, and increasing preference for minimally invasive surgeries. However, factors such as high procedure costs, unfavorable reimbursement policies, loss of tensile strength and product recall or failure are expected to restrict the market growth during the forecast period.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6231
Segmentation
The global textile implants market is segmented on the basis of product type, systems, and end-user. The textile implants market, by product type categorized into 2D implantable forms, 3D implantable forms, natural textile implants and synthetic textile implants. The synthetic textile category includes polyamide, polyester, polyethylene, polypropylene, resorbable polymers and non-resorbable polymers. Application segment is segmented into hernia repair products, cardiovascular, sports medicine, diabetic wound care, ophthalmology, and breast reconstruction. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others.
Regional Analysis
The Americas is expected to dominate the textile implants market during the forecast period. The rise in the occurrence of cardiovascular diseases drives the market in this region. Textile implants (graft and stent) are used to replace the diseased artery. According to the American Heart Association 2017, 45.1% of the cardiovascular disease deaths in the U.S. were due to Coronary Heart Disease (CHD). This influences the market growth during the forecast period.
Europe (UK, Belgium, France, & Netherlands) is second in the market owing to the increasing accidents and injuries and growing healthcare expenditure. According to the Eurostat in 2014, 152 thousand deaths in Europe were due to accidents and injuries.
Asia Pacific is expected to observe growth for the global textile implants market owing to increasing prevalence of breast cancer, rising geriatric population and rising preference for minimally invasive procedures. According to the General Re Corporation in 2016, 404,000 cases of breast cancer were diagnosed in Asia, with the highest incidence rates in China, Japan, and Indonesia.
Thus, providing favorable backgrounds for the market to grow.
The Middle East and Africa accounts for least textile implants market share due to Technical complexity, high cost, stringent government policies and low per capita income.
Key Players
Some of the key players for the global textile implants market are SERAG-WIESSNER GmbH & Co. KG Zum Kugelfang, LARS (France), Johnson and Johnson, Neoligaments (UK), Surgicraft Inc., Cousin Biotech (France), Xenotech, Orthomed S.A.S. (France), WL Gore, FX Solutions (France), Aran Biomedical, Shanghai PINE&POWER Biotech (China), and Mathys AG Bettlach (Switzerland) and other.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/textile-implants-market-6231
